全文获取类型
收费全文 | 267篇 |
免费 | 22篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 4篇 |
妇产科学 | 2篇 |
基础医学 | 45篇 |
口腔科学 | 17篇 |
临床医学 | 18篇 |
内科学 | 59篇 |
皮肤病学 | 6篇 |
神经病学 | 12篇 |
特种医学 | 6篇 |
外科学 | 62篇 |
综合类 | 3篇 |
预防医学 | 7篇 |
眼科学 | 4篇 |
药学 | 10篇 |
肿瘤学 | 16篇 |
出版年
2023年 | 7篇 |
2022年 | 11篇 |
2021年 | 18篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 16篇 |
2017年 | 11篇 |
2016年 | 20篇 |
2015年 | 15篇 |
2014年 | 17篇 |
2013年 | 13篇 |
2012年 | 17篇 |
2011年 | 15篇 |
2010年 | 5篇 |
2009年 | 9篇 |
2008年 | 15篇 |
2007年 | 16篇 |
2006年 | 21篇 |
2005年 | 14篇 |
2004年 | 9篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2001年 | 4篇 |
2000年 | 2篇 |
1999年 | 2篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1980年 | 1篇 |
1957年 | 1篇 |
排序方式: 共有290条查询结果,搜索用时 15 毫秒
281.
282.
Gadelhak Basma Tawfik Ahmed M. Saleh Gehad A. Batouty Nihal M. Sobh Donia M. Hamdy Omar Refky Basel 《Abdominal imaging》2019,44(6):2254-2261
Abdominal Radiology - To evaluate whether extending the MRI scan to include the abdomen at the time of adnexal mass characterization could replace additional CT for peritoneal cancer index (PCI)... 相似文献
283.
Rahul S. Dalal Ashraf A. Sabe Nassrene Y. Elmadhun Basel Ramlawi Frank W. Sellke 《Brazilian Journal Of Cardiovascular Surgery》2015,30(5):520-532
OBJECTIVE
Atrial fibrillation and neurocognitive decline are common complications after cardiopulmonary bypass. By utilizing genomic microarrays we investigate whether gene expression is associated with postoperative atrial fibrillation and neurocognitive decline.METHODS
Twenty one cardiac surgery patients were prospectively matched and underwent neurocognitive assessments pre-operatively and four days postoperatively. The whole blood collected in the pre-cardiopulmonary bypass, 6 hours after-cardiopulmonary bypass, and on the 4th postoperative day was hybridized to Affymetrix Gene Chip U133 Plus 2.0 Microarrays. Gene expression in patients who developed postoperative atrial fibrillation and neurocognitive decline (n=6; POAF+NCD) was compared with gene expression in patients with postoperative atrial fibrillation and normal cognitive function (n=5; POAF+NORM) and patients with sinus rhythm and normal cognitive function (n=10; SR+NORM). Regulated genes were identified using JMP Genomics 4.0 with a false discovery rate of 0.05 and fold change of >1.5 or <-1.5.RESULTS
Eleven patients developed postoperative atrial fibrillation. Six of these also developed neurocognitive decline. Of the 12 patients with sinus rhythm, only 2 developed neurocognitive decline. POAF+NCD patients had unique regulation of 17 named genes preoperatively, 60 named genes six hours after cardiopulmonary bypass, and 34 named genes four days postoperatively (P<0.05) compared with normal patients. Pathway analysis demonstrated that these genes are involved in cell death, inflammation, cardiac remodeling and nervous system function.CONCLUSION
Patients who developed postoperative atrial fibrillation and neurocognitive decline after cardiopulmonary bypass may have differential genomic responses compared to normal patients and patients with only postoperative atrial fibrillation, suggesting common pathophysiology for these conditions. Further exploration of these genes may provide insight into the etiology and improvements of these morbid outcomes. 相似文献284.
Gilbert H.L. Tang Aditya Sengupta Sophia L. Alexis Vinayak N. Bapat David H. Adams Samin K. Sharma Annapoorna S. Kini Susheel K. Kodali Basel Ramlawi Hemal Gada Amit N. Vora John K. Forrest Ryan K. Kaple Fang Liu Michael J. Reardon 《JACC: Cardiovascular Interventions》2021,14(9):964-976
ObjectivesThe aim of this study was to assess the outcomes of severe prosthesis-patient mismatch (PPM) in the TVT (Transcatheter Valve Therapy) Registry in patients undergoing supra-annular transcatheter aortic valve replacement (TAVR) for de novo stenosis or failed surgical bioprostheses (transcatheter aortic valve [TAV]–in–surgical aortic valve [SAV]).BackgroundSevere PPM has been associated with adverse outcomes following TAVR, yet the clinical outcome of severe PPM after supra-annular TAVR is largely unknown.MethodsSupra-annular TAVR was performed in patients enrolled in the TVT Registry with de novo stenosis (n = 42,174) or TAV-in-SAV (n = 5,446). Valve Academic Research Consortium-3 criteria were used to define severe PPM. The clinical impact of severe PPM on 1-year mortality and valve-related readmission was assessed using multivariate regression. A generalized linear mixed model was used to evaluate predictors of severe PPM.ResultsSevere PPM was found in 5.3% of patients undergoing de novo TAVR and 27.0% of patients undergoing TAV-in-SAV. The presence of severe PPM was not significantly associated with 1-year mortality or valve-related readmissions in both groups. Mean aortic gradients were higher in patients with severe PPM than in those without severe PPM at 1 month (9.7 ± 5.7 mm Hg vs. 7.3 ± 4.0 mm Hg; p < 0.001) and 1 year (10.2 ± 6.4 mm Hg vs. 8.0 ± 4.3 mm Hg; p < 0.001). Pre-procedural factors, including a <20-mm aortic annulus, were positive predictors of severe PPM in patients undergoing de novo TAVR (area under the curve = 0.795) and TAV-in-SAV (area under the curve = 0.764).ConclusionsSevere PPM after supra-annular TAVR was not associated with increased 1-year mortality or valve-related readmissions. Longer-term follow-up is needed to determine if higher residual gradients in patients with severe PPM predict long-term outcomes. (STS/ACC Transcatheter Valve Therapy Registry [TVT Registry]; NCT01737528) 相似文献
285.
286.
287.
Martin AP Goldstein RM Dempster J Netto GJ Katabi N Derrick HC Altrabulsi B Jennings LW Ueno T Chinnakotla S Dawson S Randall HB Levy MF Onaca N Sanchez EQ Orr D Klintmalm GB 《Clinical transplantation》2006,20(6):695-705
BACKGROUND: Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) is an optional treatment for patients awaiting liver transplantation (LTX). The study evaluates the efficacy of RFA in the explanted liver and its effect on patient outcome. MATERIAL AND METHOD: Forty-seven patients underwent RFA and were listed for transplant between January 1998 and May 2003. The patients were divided into two groups: transplanted and non-transplanted. Both groups were evaluated in terms of tumor characteristics, recurrence, mortality rate, and time on the waiting list. The ablation sites in the explanted livers were examined for percentage of necrosis by Hematoxylin & Eosin (H&E) stain and by TUNEL stain. RESULTS: Transplantation was carried out in 35 patients (74.5%). Ten patients (21.3%) died before transplant or were removed from the wait list, while two patients (4.2%) are still listed. Mortality and tumor-related mortality were significantly higher in the non-transplanted group. The time spent on the waiting list was longer in the non-transplanted patients (350 vs. 186 d average, p = 0.0345). Thirty-eight ablation sites were examined in the explanted livers. The percentage of tumor necrosis by TUNEL staining was 19.6% higher than that reported by H&E staining. After TUNEL staining, 28 sites (73.7%) had more than 90% necrosis, eight sites (21.0%) had 50-90%, and two sites (5.3%) had less than 50% necrosis. CONCLUSIONS: RFA and LTX can be used successfully in HCC patients, and in most cases, tumor necrosis can be achieved with ultrasound-guided RFA. H&E stain tends to under-represent the amount of tumor necrosis on the ablation sites. Survival of RFA patients after LTX is excellent. 相似文献
288.
El-Sabbagh Basel Gutmann Pauline Holzrichter Hannah Güth Jan-Frederik Graf Tobias 《Der Freie Zahnarzt》2022,66(9):78-83
Der Freie Zahnarzt - 相似文献
289.
Anjali S. Advani William Tse Hong Li Xuefei Jia Paul Elson Brenda Cooper Francis Ali-Osman Jino Park Arati V. Rao David A. Rizzieri Eunice S. Wang Claudiu V. Cotta Matt Kalaycio Ronald M. Sobecks Basel Rouphail Jaroslaw P. Maciejewski Jaime Fensterl Jennifer S. Carew Mikkael A. Sekeres 《Clinical Lymphoma, Myeloma & Leukemia》2021,21(2):113-118
IntroductionAdults with acute myeloid leukemia (AML) have a high rate of remission; however, more than 50% relapse. C-kit is expressed in approximately 60% of patients with de novo AML and represents a potential therapeutic target.Materials and MethodsPatients with newly diagnosed AML received 12 months of imatinib mesylate as maintenance therapy after the completion of post-remission therapy. The primary objective was to determine whether this approach improved progression-free survival (defined as no relapse and no death) compared with historical controls.ResultsThe median progression-free survival of patients < 60 years of age was 52.1 months (historical control, 13 months) and for patients ≥ 60 years of age was 10.7 months (historical control, 8 months). The median level of AF1q expression was high (9.59), and 84% of patients had moderate or high levels of drug-resistance factors.ConclusionsImatinib maintenance therapy may improve the outcome of newly diagnosed patients with AML who are < 60 years of age. 相似文献
290.
Abdul Rahman Al Armashi Francisco J. Somoza-Cano Kanchi Patell Mohamed Homeida Omkar Desai Anas Al Zubaidi Basel Altaqi Keyvan Ravakhah 《Radiology Case Reports》2021,16(12):3655
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our patient is a 49-year-old male who presented with shortness of breath and cough. A COVID-19 Polymerase Chain Reaction was positive. He required a high-flow nasal cannula, but he did not demand mechanical ventilation. Computed tomography angiography scan of the chest revealed pneumomediastinum. He was managed conservatively, and a complete recovery was achieved. This case highlights the emerging association of COVID-19, patient self-inflicted lung injury, and pneumomediastinum. Furthermore, spontaneous pneumomediastinum should be suspected even in patients who were not mechanically ventilated. 相似文献